Xiaojian Zhu

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursCharacterisation of biological macromoleculesMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jul 17, 2026
Serglycin-ROS axis mediates synergistic lethality of PI3Kγ inhibition and Azacitidine in TP53-mutated AML.

|Mar 13, 2026
Correction to: Significance of targeting DNMT3A mutations in AML.

Guiqin Huang, Xiaoya Cai, Dengju Li

|Aug 25, 2025
CD44v6 CAR-T Cells Target DNMT3A-Mutant AML: Synergistic Enhancement by Decitabine.

Hui-Min Li, Yi-Mei Que, Xiao-Ya Cai

|Apr 23, 2025
Targeting Calprotectin S100A8/A9 to Overcome AML Progression in DNMT3A-Mutant Cells.

Xiao-Ya Cai, Gui-Qin Huang, Ye-Ming Zhou

|Sep 10, 2024
Global, regional, and national burden of acute myeloid leukemia, 1990-2021: a systematic analysis for the global burden of disease study 2021.

Yeming Zhou, Guiqin Huang, Xiaoya Cai

|Jul 30, 2024
Significance of targeting DNMT3A mutations in AML.

Guiqin Huang, Xiaoya Cai, Dengju Li

Pageof 2

Frequent Collaborators

2 joint publications

Xiuhua Sun

2 joint publications

Hang Su

2 joint publications

Zengjun Li

2 joint publications

Zhiming Li